Project Sleep’s President & CEO, Julie Flygare, JD, will be a featured speaker in The Washington Post’s event ahead of Rare Disease Day: Innovations in research and treatment for rare diseases.
More than 30 million people in the United States are affected by rare diseases, many of which are life-threatening conditions without available treatments. On Thursday, Feb. 27 at 12noon ET, join Post Live for conversations about the latest efforts to advance medical research, the possibilities spurred by AI and the critical role of caregivers.
Flygare will speak alongside Boomer Esiason, Co-Chair, Boomer Esiason Foundation; Pamela Gavin, CEO, National Organization for Rare Diseases; Marshall Summar, CEO, Uncommon Cures; and Cate McCanless, Chief Corporate Affairs Officer, Harmony Biosciences.
“Innovations in research and treatment for rare diseases,” will discuss the latest efforts to advance medical research, the new possibilities spurred by artificial intelligence and the critical role of caregivers. Celebrate Rare Disease Day with us by registering for this special Washington Post event here!
Special thanks to Harmony Biosciences for including Project Sleep in this wonderful opportunity to share the importance of social support for people and families facing rare diseases.
